Erlocip 150 Mg Tablets

Name: Erlocip 150 Mg Tablets
Brand: BHAVYA ENTERPRISES
Price: 2500 INR
Availability: InStock

Price 2500 INR/ Bottle

Get a Price/Quote

MOQ : 100 Bottles

Erlocip 150 Mg Tablets Specification

Life Span
18 months

Packaging Type
Box

Brand Name
Cipla

Origin of Medicine
India

Dosage
150 mg

Quantity
1*10 Tablets

Solid oral tablet
Physical Form

Prescription only
Drug Type

Erlotinib 150 mg
Salt Composition

Box of 10 tablets
Pacakaging (Quantity Per Box)

Hospital use
Recommended For

Titanium dioxide
Ingredients

As directed by physician
Dosage Guidelines

Lung and pancreatic cancer
Indication

Oncology medication
Function

Tablet
Dosage Form

Store below 30°C
Storage Instructions

Adults only
Suitable For

Erlocip 150 Mg Tablets Trade Information

Minimum Order Quantity
100 Bottles

Payment Terms
Cash in Advance (CID)

Supply Ability
5000 Bottles Per Month

Delivery Time
2-10 Days

Main Domestic Market
All India

About Erlocip 150 Mg Tablets

Commanding in its therapeutic effectiveness, Erlocip 150 Mg Tablets from Cipla represent an elite choice for targeted oncology care. This sublime deal delivers the power of erlotinib 150 mg as a solid oral tablet, designed for prescription-only use in adult patients. Gloriously formulated with titanium dioxide, each box contains 10 tablets to help support those battling lung and pancreatic cancers. Exclusively intended for hospital use, Erlocip must be stored below 30C and taken strictly as directed by a physician. Act now - this ending soon, top-rated offer assures authentic supply from trusted Indian traders.

Superior Application and Versatile Features

Erlocip 150 Mg Tablets are specifically crafted for plant-based oncology treatment settings, offering both potent features and precision-driven usage. Designed for adults, this oral tablet works with a direct mode of action on cancer cells. With its sublime efficacy, Erlocip is well-suited for frequent clinical application, ensuring commanding results and seamless integration within established hospital protocols.

Global Supply, Secure Payment, and Streamlined Packaging

Our reach spans a glorious export market, regularly supplying Erlocip 150 Mg Tablets to leading healthcare facilities worldwide. Handed over under strict protocols, each box (1x10 tablets) is securely packed for drop-off or scheduled delivery. With flexible payment terms, including advance, TT, and LC, we ensure prompt and flawless transaction and supply every time, directly from India's top pharmaceutical traders.

FAQ's of Erlocip 150 Mg Tablets:

Q: How should Erlocip 150 Mg Tablets be used for oncology treatment?

A: Erlocip 150 Mg Tablets must be taken orally by adults as prescribed by a physician, typically once daily. Dosage should not be adjusted without medical supervision, and regular monitoring is advised during use.

Q: What cancers can Erlocip 150 Mg Tablets treat?

A: Erlocip 150 Mg Tablets are indicated for the management of lung and pancreatic cancers. Their targeted action helps inhibit the growth of specific cancer cells, providing effective support in oncology regimens.

Q: When is Erlocip 150 Mg recommended for patients?

A: This medication is recommended for adult patients diagnosed with either lung or pancreatic cancer and is to be used under hospital supervision as directed by an oncologist.

Q: Where should Erlocip 150 Mg Tablets be stored after purchase?

A: Erlocip 150 Mg Tablets should be stored in their original packaging below 30C to maintain stability and efficacy until the stated expiry date.

Q: What is the packaging and ingredient information for Erlocip 150 Mg Tablets?

A: Each box contains 10 tablets, each with 150 mg of erlotinib, and includes titanium dioxide among its inactive ingredients. The tablets ship in a secure box packaging from Cipla.

Q: How can one benefit from timely procurement of Erlocip 150 Mg Tablets?

A: By securing this elite deal promptly, healthcare providers gain access to a commanding oncology solution sourced directly from reputable suppliers, ensuring authenticity and traceability for patient safety.

Tell us about your requirement